Medindia

Long-Term Effects of PectaSol-C Modified Citrus Pectin Against Biochemically Relapsed Prostate Cancer--Updated Results from a Phase IIb Clinical Trial

SANTA ROSA, Calif., Jan. 2, 2020 /PRNewswire/ -- Better Health Publishing—A multi-center Phase IIb clinical trial conducted in Israel, has been studying the effects of a dietary supplement, modified ...
ascopubs.org

Effect of PectaSol-C modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in patients (pts) with nonmetastatic, biochemically relapsed prostate cancer (BRPC): Results ...

Sexual function, quality of life, and cancer-related distress among prostate cancer survivors. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not include a ...
ascopubs.org

Effect of pectasol-c modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in non-metastatic biochemically relapsed prostate cancer (BRPC) patients (pts): Results of a ...

The association between physician trust and prostate specific antigen screening: Implications for shared decision making. This is an ASCO Meeting Abstract from the 2018 Genitourinary Cancers Symposium ...